| Primary |
| Asthma |
50.7% |
| Chronic Obstructive Pulmonary Disease |
12.7% |
| Hypersensitivity |
7.7% |
| Hypertension |
4.9% |
| Emphysema |
3.9% |
| Product Used For Unknown Indication |
3.2% |
| Dyspnoea |
1.8% |
| Seasonal Allergy |
1.8% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Supplementation Therapy |
1.4% |
| Vitamin Supplementation |
1.4% |
| Arthritis |
1.1% |
| Bronchiectasis |
1.1% |
| Bronchitis Chronic |
1.1% |
| Cough |
1.1% |
| Diabetes Mellitus |
1.1% |
| Diuretic Therapy |
1.1% |
| Hypothyroidism |
1.1% |
| Sleep Disorder |
1.1% |
| Blood Cholesterol Increased |
0.7% |
|
| Drug Ineffective |
21.1% |
| Dyspnoea |
13.7% |
| Asthma |
7.5% |
| Drug Effect Decreased |
7.5% |
| Wheezing |
5.0% |
| Candidiasis |
4.3% |
| Insomnia |
4.3% |
| Cough |
3.7% |
| Incorrect Dose Administered |
3.1% |
| Malaise |
3.1% |
| Off Label Use |
3.1% |
| Oropharyngeal Pain |
3.1% |
| Psychomotor Hyperactivity |
3.1% |
| Throat Irritation |
3.1% |
| Anger |
2.5% |
| Lung Disorder |
2.5% |
| Palpitations |
2.5% |
| Pneumonia |
2.5% |
| Urticaria |
2.5% |
| Abnormal Behaviour |
1.9% |
|
| Secondary |
| Asthma |
35.6% |
| Chronic Obstructive Pulmonary Disease |
16.2% |
| Emphysema |
8.1% |
| Bronchitis |
6.5% |
| Hypersensitivity |
4.0% |
| Hypertension |
4.0% |
| Dyspnoea |
3.6% |
| Product Used For Unknown Indication |
2.8% |
| Sleep Disorder |
2.4% |
| Drug Abuse |
2.0% |
| Malaise |
2.0% |
| Urinary Tract Infection |
2.0% |
| Cough |
1.6% |
| Muscle Spasms |
1.6% |
| Arthritis |
1.2% |
| Back Pain |
1.2% |
| Bronchitis Chronic |
1.2% |
| Prophylaxis |
1.2% |
| Rhinorrhoea |
1.2% |
| Seasonal Allergy |
1.2% |
|
| Asthma |
13.0% |
| Urinary Tract Infection |
10.9% |
| Dyspnoea |
8.7% |
| Rhinorrhoea |
8.7% |
| Bronchitis |
6.5% |
| Pneumonia |
6.5% |
| Vomiting |
6.5% |
| Death |
4.3% |
| Drug Ineffective |
4.3% |
| Hepatic Cancer |
4.3% |
| Inappropriate Schedule Of Drug Administration |
4.3% |
| Pleural Effusion |
4.3% |
| Acute Generalised Exanthematous Pustulosis |
2.2% |
| Candida Infection |
2.2% |
| Cerebrovascular Accident |
2.2% |
| Depressed Mood |
2.2% |
| Gallbladder Disorder |
2.2% |
| Glossodynia |
2.2% |
| Heart Rate Increased |
2.2% |
| Hypertension |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.2% |
| Asthma |
19.5% |
| Chronic Obstructive Pulmonary Disease |
7.3% |
| Hypertension |
4.4% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Anxiety |
2.4% |
| Hypersensitivity |
2.4% |
| Pain |
2.3% |
| Depression |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Dyspnoea |
1.6% |
| Diabetes Mellitus |
1.3% |
| Atrial Fibrillation |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Hepatitis C |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Pulmonary Arterial Hypertension |
1.0% |
| Bipolar Disorder |
1.0% |
| Emphysema |
1.0% |
| Wheezing |
1.0% |
|
| Product Quality Issue |
10.7% |
| Dyspnoea |
8.1% |
| Vomiting |
7.1% |
| Sinusitis |
6.1% |
| Visual Impairment |
6.1% |
| Pain |
5.6% |
| Vision Blurred |
5.6% |
| Wheezing |
5.6% |
| Weight Increased |
5.1% |
| Off Label Use |
4.6% |
| Pneumonia |
4.6% |
| Pulmonary Embolism |
4.6% |
| Drug Ineffective |
4.1% |
| Asthma |
3.6% |
| Malaise |
3.6% |
| Aggression |
3.0% |
| Insomnia |
3.0% |
| Overdose |
3.0% |
| Somnolence |
3.0% |
| Suicidal Ideation |
3.0% |
|
